US Patent Issued to MYOKARDIA on Nov. 4 for "Polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1- fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide" (French, American Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,919, issued on Nov. 4, was assigned to MYOKARDIA INC. (Brisbane, Calif.).

"Polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1- fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide" was invented by Min Zhong (Palo Alto, Calif.), Olivier Monnier (Villeveyrac, France), Jean-Philippe Jelin (Montpellier, France), Richard Duvoux (Montpellier, France), Jean Alie (Montpellier, France) and Philippe Ochsenbein (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel polymorphs of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-N-(isoxazol-3-yl...